Novo Nordisk (NVO) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...

Novo Nordisk’s India team wants to launch the weight-loss drug Wegovy sooner than planned. They’re concerned about falling behind the company’s rival, Eli Lilly, whose similar drug Mounjaro ...

After slashing the U.S. prices of several of its insulin products by 75% at the start of 2024, Novo Nordisk is ending the year by announcing similar price reductions for most of its other insulins ...

Key Market Players in the Indian Diabetes Care Market include Sanofi, Novo Nordisk India, USV, Novartis, Merck, Becton ...

In the latest trading session, Novo Nordisk (NVO) closed at $108.82, marking a -0.14% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.19% for the day.

Catalent and Novo Holdings—a holding company distinct from the Danish drugmaker Novo Nordisk—said the European Commission (EC) has granted “unconditional approval” to the companies ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer. By taking this step, the executive arm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...